European Hematology Association Congress, June 9-12
Jun 10, 2022 from 4:30 PM to 5:45 PM CEST
Safety and efficacy findings of AUTO1, a fast off-rate CD19 CAR, in relapsed/refractory B-Cell Non-Hodgkin’s Lymphoma (B-NHL), and chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Supporting Materials
Read abstract 154.1 KB